rxstat › Shortages › Flurazepam

Flurazepam (Som-Pam) shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Flurazepam is in a widespread shortage in Canada. 4 of 6 reported products are affected. Manufacturers have not committed to a recovery date.

A benzodiazepine sleep medication used to treat insomnia.

Products affected
4 / 6
In shortage since
May 30, 2012
Reports on file
8
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
SOM-PAM
BIOMED PHARMA
DIN 00414239 · since Oct 23, 2014, no end estimate · DORMANT
Active shortage
SOM-PAM
BIOMED PHARMA
DIN 00414239 · since Oct 23, 2014, no end estimate · DORMANT
Active shortage
SOM-PAM
BIOMED PHARMA
DIN 00414220 · since Oct 23, 2014, no end estimate · DORMANT
Active shortage
SOM-PAM
BIOMED PHARMA
DIN 00414220 · since Oct 23, 2014, no end estimate · DORMANT
Active shortage
BIO-FLURAZEPAM
BIOMED PHARMA
DIN 02248127 · since May 30, 2012, no end estimate · DORMANT
Active shortage
BIO-FLURAZEPAM
BIOMED PHARMA
DIN 02248126 · since May 30, 2012, no end estimate · DORMANT
Discontinued
FLURAZEPAM 15
15MG · CAPSULE · PRO DOC LIMITEE
DIN 00578479
Discontinued
FLURAZEPAM 30
30MG · CAPSULE · PRO DOC LIMITEE
DIN 00578487

What's happening

Flurazepam is currently affected by 4 active shortage reports filed with Health Canada by BIOMED PHARMA.

The reported cause is: dormant. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Flurazepam is classified under “HYPNOTICS AND SEDATIVES” (ATC N05CD01).

Recent changes

Common questions

What is Flurazepam used for?

A benzodiazepine sleep medication used to treat insomnia.

When will Flurazepam be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Flurazepam in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (hypnotics and sedatives)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Dexmedetomidine (Precedex) No current shortage Midazolam No current shortage Zolpidem (Sublinox) Partial shortage 2 of 8 reported products affected · est. return Nov 20, 2026 Zopiclone (Imovane) Partial shortage 6 of 24 reported products affected · est. return Oct 27, 2026 Scopolamine Widespread shortage 2 of 4 reported products affected · est. return Aug 14, 2026 Suvorexant (Belsomra) Discontinued 0 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.